19 June 2013
Keywords: gsk, submits, snda, fda, advir, diskus, uk-based
Article | 16 October 2006
UK-based pharmaceutical major GlaxoSmithKline says it has submitted a supplemental New Drug Application to the US Food and Drug Administration
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 October 2006
18 June 2013
© 2013 thepharmaletter.com